Powerful Bactericidal Activity of Moxifloxacin in Human Leprosy

In a clinical trial of moxifloxacin in eight multibacillary leprosy patients, moxifloxacin proved highly effective. In all trial patients, a single 400-mg dose of moxifloxacin resulted in significant killing (P ≤ 0.006) of Mycobacterium leprae, ranging from 82% to 99%, with a mean of 91%. In all ins...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pardillo, Fe Eleanor F., Burgos, Jasmin, Fajardo, Tranquilino T., Cruz, Eduardo Dela, Abalos, Rodolfo M., Paredes, Rose Maria D., Andaya, Cora Evelyn S., Gelber, Robert H.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2008
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533472/
https://ncbi.nlm.nih.gov/pubmed/18573938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01162-07
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky